{"brief_title": "Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)", "brief_summary": "The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved cholesterol lowering medication.", "detailed_description": "The duration of treatment is 10 weeks.", "condition": ["Hypercholesterolemia", "Coronary Disease"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0653, ezetimibe", "Comparator: ezetimibe, placebo"], "criteria": "Inclusion Criteria: - Patients with elevated cholesterol and coronary heart disease Exclusion Criteria: - Patients who have cholesterol levels within normal ranges as identified by the study", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Elevated Cholesterol", "mesh_term": ["Heart Diseases", "Hypercholesterolemia", "Coronary Disease", "Coronary Artery Disease", "Myocardial Ischemia", "Ezetimibe"], "id": "NCT00092625"}